Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AAN 2024 | Disease-modifying gene therapies for common epilepsies

Jacqueline French, MD, from NYU Comprehensive Epilepsy Center, New York, NY, expresses her excitement about disease-modifying gene therapies for epilepsy. At the moment, these therapies are for specific rare epilepsies; however research is ongoing to treat more common epilepsies. Research into both cell therapies and gene therapies are underway to treat temporal lobe epilepsy, with the aim of addressing the underlying disease rather than treatment solely with anti-seizure medication. This interview took place at the American Academy of Neurology (AAN) Annual Meeting 2024 in Denver, CO.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.